Certified stroke centers more likely to use tPA, data show

03/28/2013 | MedPage Today (free registration)

Data from the Nationwide Inpatient Sample show more stroke patients treated at certified primary stroke centers got intravenous recombinant tissue plasminogen activator therapy compared with patients treated at other hospitals, University of Pennsylvania researchers reported in the Journal of the American Heart Association. Use of tPA increased at both certified and noncertified centers during the study period, however, researchers said.

View Full Article in:

MedPage Today (free registration)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
ASAHI INTECC
Multiple Locations, SL_Multiple Locations
Vice President of Regulatory Affairs
Pentec Health
Boothwyn, PA
Sr Coordinator Clinical Research (US/TA/00/0073/SL) - 1400000AQX
Abbott
Santa Clara, CA
Senior Director, Biostatistics
Edwards Lifesciences
Irvine, CA